Global Ophthalmology Amniotic Membranes Market Overview
Amniotic membrane is the innermost placental layer with thick basement membrane and an avascular stromal matrix. Human amniotic membranes are derived from inner amniotic fetal membranes which is made up of single layer of amnion cell and attached to chorion. It is a natural and wonderful biological membrane which not only protects the fetus but also can be used in the field of clinical applications such as ophthalmology, dermatology, dental surgery, Ear, Nose, Throat (ENT) surgery, orthopedics, etc. Amniotic membrane is widely used in eye surgery as a graft and dressing to facilitate healing and reconstruction of ocular surface. It is lightweight, elastic, thin and transparent due to which it can be used on the surface of eye.
Ophthalmology amniotic membranes market is driven by increasing adoption of amniotic membrane for various applications across the globe. The increased R&D investments in the field of ophthalmology amniotic membrane have led to more focused research across the globe. Furthermore, increased regulatory harmonization for accelerated pace of product approvals has made an increase in the target market. Besides these, the membrane transplants are like to increase by increase in the number of techniques for transplantation of amniotic membrane. Also fast approval of the amniotic based products to treat the surgical wounds contributes to the growth of the ophthalmology amniotic membrane market. The safety, convenience, and effectiveness of amniotic membranes are helping to produce excellent outcomes and treat a variety of ocular surface diseases. Amniotic membranes as an ideal biological dressing in ophthalmology is being used worldwide and in turn driving growth of the target market. However, some factors restraining growth of the global market including lack of skilled and experienced professionals, time to reach market due to lengthy clinical trials, lack of standardized procedure and guidelines on tissue engineering across the globe.
Ophthalmology amniotic membrane market is segmented on the basis of product type, end user and region. On the basis of product type the target market is segmented into cryopreserved and lyophilized. On the basis of end user, the target market is classified into hospitals, ambulatory surgical centers, specialized clinics, research centers and laboratory. On the basis of region, the market is classified as North America, Europe, Asia-Pacific, South America, Middle East and Africa.
Among the regions, North America is leading the global market for ophthalmologyamniotic membrane with maximum number of shares due to the presence of the large number of key companies in the region. European region is at the second highest revenue as its healthcare system is publicly funded and universal healthcare systems are adopted. The Asia-Pacific region is more likely to expand at the highest in the coming period as most of the countries in this region are economically developing and their income is gradually increasing. Also many multinational companies are investing in this region with a great interest.
Global Ophthalmology Amniotic Membranes Market Competitive Landscape & Key Players
Key players operating in the ophthalmology amniotic membranes market includes Amniox Medical, Inc., FzioMed, Inc., Human Regenerative Technologies, LLC., Amnio Technology, LLC., Applied Biologics LLC., Alliqua BioMedical, Inc., Derma Sciences Inc., MiMedx Group, Inc. and Skye Biologics Inc.
FAQs
Ophthalmology amniotic membrane market is segmented on the basis of product type, end-user, and region
Ophthalmology amniotic membranes market is driven by the increasing adoption of amniotic membranes for various applications across the globe. The increased R&D investments in the field of ophthalmology amniotic membranes have led to more focused research across the globe.
North America is leading the global market for ophthalmologyamniotic membrane with the maximum number of shares due to the presence of a large number of key companies in the region.
The prominent key operating in the global market have adopted key strategies such as collaborations, mergers, acquisitions, and partnerships to strengthen their market outreach and sustain the stiff competition in the market. For instance, in January 2020, Amniox Medical, Inc., a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced the results from a single-center, prospective, investigator-initiated pilot study titled “Injectable Amniotic Membrane/Umbilical Cord Particulate for Knee Osteoarthritis.”